Clinical Trial Update: Treatment of NF1-related Plexiform Neurofibroma With Trametinib [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating trametinib for NF1-related plexiform neurofibroma is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibroma Plexiform
• Neurofibromatosis Type

Drugs mentioned

• Trametinib (trametinib)

Snippet

Sponsor: Region Skane | Conditions: Neurofibromatosis 1, Child | Phase 2 | Status: ACTIVE_NOT_RECRUITING